Benign Paroxysmal Positional Vertigo (BPPV)
9
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (9)
Association Between Benign Paroxysmal Positional Vertigo and Vitamin D Deficiency .
Testing the Epley Maneuver for Treating Dizziness in the Emergency Department: A Randomized Study
Prevalence av BPPV Among Elderly in Primary Care
Effects of Epleys Maneuver Versus Semont-Plus Maneuver Combined with Brandt-Daroff Exercises on Dizziness and Quality of Life in Benign Paroxysmal Positional Vertigo
The CAVA Multicentre Dizziness Trial
Metabolic Disorders and Vertigo
Vertistop® D and Vertistop® L in Preventing Recurrence of High-recurrence BPPV
BPPV With CRP: Single Versus Multiple Cycles
Treatment of Posterior Canal Type of Benign Paroxysmal Positional Vertigo